| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |